Pharma could see a wave of M&A activity in 2024, says Jefferies' Michael Yee
0
0
17/01/24
Dans
Amérique du Nord / États-Unis
Michael Yee, Jefferies senior biotech analyst, joins 'Fast Money' to talk dealmaking in the pharma sector in 2024.
Montre plus
0 commentaires
sort Trier par